Department of Cardiology, Odense University Hospital, J. B. Winsloews Vej 4, 5000, Odense C, Denmark.
Department of Clinical Research, University of Southern Denmark, Odense, Denmark.
Crit Care. 2024 May 18;28(1):169. doi: 10.1186/s13054-024-04936-w.
Acute kidney injury (AKI) is a significant risk factor associated with reduced survival following out-of-hospital cardiac arrest (OHCA). Whether the severity of AKI simply serves as a surrogate measure of worse peri-arrest conditions, or represents an additional risk to long-term survival remains unclear.
This is a sub-study derived from a randomized trial in which 789 comatose adult OHCA patients with presumed cardiac cause and sustained return of spontaneous circulation (ROSC) were enrolled. Patients without prior dialysis dependent kidney disease and surviving at least 48 h were included (N = 759). AKI was defined by the kidney disease: improving global outcome (KDIGO) classification, and patients were divided into groups based on the development of AKI and the need for continuous kidney replacement therapy (CKRT), thus establishing three groups of patients-No AKI, AKI no CKRT, and AKI CKRT. Primary outcome was overall survival within 365 days after OHCA according to AKI group. Adjusted Cox proportional hazard models were used to assess overall survival within 365 days according to the three groups.
In the whole population, median age was 64 (54-73) years, 80% male, 90% of patients presented with shockable rhythm, and time to ROSC was median 18 (12-26) min. A total of 254 (33.5%) patients developed AKI according to the KDIGO definition, with 77 requiring CKRT and 177 without need for CKRT. AKI CKRT patients had longer time-to-ROSC and worse metabolic derangement at hospital admission. Overall survival within 365 days from OHCA decreased with the severity of kidney injury. Adjusted Cox regression analysis found that AKI, both with and without CKRT, was significantly associated with reduced overall survival up until 365 days, with comparable hazard ratios relative to no AKI (HR 1.75, 95% CI 1.13-2.70 vs. HR 1.76, 95% CI 1.30-2.39).
In comatose patients who had been resuscitated after OHCA, patients developing AKI, with or without initiation of CKRT, had a worse 1-year overall survival compared to non-AKI patients. This association remains statistically significant after adjusting for other peri-arrest risk factors.
The BOX trial is registered at ClinicalTrials.gov: NCT03141099.
急性肾损伤(AKI)是与院外心脏骤停(OHCA)后生存率降低相关的重要危险因素。急性肾损伤的严重程度是否仅仅是心脏骤停前情况恶化的替代指标,或者是否代表长期生存的额外风险仍不清楚。
这是一项从一项随机试验中衍生的子研究,该研究纳入了 789 名昏迷的成年 OHCA 患者,这些患者均有心脏骤停的推测病因且自主循环恢复(ROSC)持续。纳入了无先前依赖透析的肾脏疾病且至少存活 48 小时的患者(N=759)。急性肾损伤的定义为肾脏疾病:改善全球预后(KDIGO)分类,根据急性肾损伤的发展和是否需要持续肾脏替代治疗(CKRT),患者分为无 AKI、AKI 无 CKRT 和 AKI CKRT 三组。主要结局是根据 AKI 组 OHCA 后 365 天的总体生存率。使用调整后的 Cox 比例风险模型根据三组评估 365 天内的总体生存率。
在整个人群中,中位年龄为 64(54-73)岁,80%为男性,90%的患者表现为可除颤节律,ROSC 时间中位数为 18(12-26)分钟。根据 KDIGO 定义,共有 254 名(33.5%)患者发生 AKI,其中 77 名需要 CKRT,177 名不需要 CKRT。AKI CKRT 患者的 ROSC 时间更长,入院时代谢紊乱更严重。从 OHCA 起 365 天内的总体生存率随肾损伤严重程度的增加而降低。调整后的 Cox 回归分析发现,无论是否进行 CKRT,AKI 均与 365 天内的总体生存率降低显著相关,与无 AKI 相比,风险比相似(HR 1.75,95%CI 1.13-2.70 与 HR 1.76,95%CI 1.30-2.39)。
在 OHCA 后接受复苏的昏迷患者中,发生 AKI 且未接受 CKRT 或开始 CKRT 的患者与非 AKI 患者相比,1 年总体生存率较差。在调整其他心脏骤停前危险因素后,这种关联仍然具有统计学意义。
BOX 试验在 ClinicalTrials.gov 注册:NCT03141099。